Senseonics/SENS

$0.41

3.94%
-
1D1W1MYTD1YMAX

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems, Eversense, Eversense XL, and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. The glucose data are automatically sent every five minutes to a mobile app on the user's smartphone. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device. Its CGM system continually and accurately measures a person's glucose levels for up to six months.

Ticker

SENS

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

Timothy Goodnow

Employees

132

Headquarters

Germantown, United States

Senseonics Metrics

BasicAdvanced
$211.9M
Market cap
-
P/E ratio
-$0.10
EPS
0.98
Beta
-
Dividend rate
$211.9M
0.97639
$1.05
$0.40
2.59M
7.535
7.026
56.084
56.084
-38.24%
-363.59%
-45.21%
9.464
5.915
2.885
36.62%
-149.48%
65.39%

What the Analysts think about Senseonics

Analyst Ratings

Majority rating from 4 analysts.
Sell

Price Targets

Average projection from 3 analysts.
297.56% upside
High $2.50
Low $0.40
$0.41
Current price
$1.63
Average price target

Senseonics Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-213.75% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$8M
33.33%
Net income
$-17.1M
-29.05%
Profit margin
-213.75%
-46.78%

Senseonics Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 29.13%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-
-$0.04
-$0.04
-$0.03
-
Expected
-$0.03
-$0.04
-$0.04
-$0.04
-$0.03
Surprise
-
3.23%
14.29%
-29.13%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Senseonics stock?

Senseonics (SENS) has a market cap of $211.9M as of April 24, 2024.

What is the P/E ratio for Senseonics stock?

The price to earnings (P/E) ratio for Senseonics (SENS) stock is 0 as of April 24, 2024.

Does Senseonics stock pay dividends?

No, Senseonics (SENS) stock does not pay dividends to its shareholders as of April 24, 2024.

When is the next Senseonics dividend payment date?

Senseonics (SENS) stock does not pay dividends to its shareholders.

What is the beta indicator for Senseonics?

Senseonics (SENS) has a beta rating of 0.98. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Senseonics stock price target?

The target price for Senseonics (SENS) stock is $1.63, which is 279.07% above the current price of $0.43. This is an average based on projections from 3 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Senseonics stock

Buy or sell Senseonics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing